Novartis ups investment in Israeli stem cell firm Gamida Cell – Seeking Alpha
BioPharma Dive |
Novartis ups investment in Israeli stem cell firm Gamida Cell
Seeking Alpha Novartis (NVS +0.2%) agrees to invest another $15M in Gamida Cell, a Jerusalem-based developer of stem cell therapies. The new investment, representing a 2.5% stake, will raise its total investment to $50M, or 17.5%. The deal could grow to $600M if … Novartis pours another $15M into Israeli stem cell company Novartis increases stake in stem cell group Is Novartis going after the cure for Leukemia? |
